Development and evaluation of RAMP I – a practitioner’s tool for screening of musculoskeletal disorder risk factors in manual handling

RAMP I is a screening tool developed to support practitioners in screening for work-related musculoskeletal disorder risk factors related to manual handling. RAMP I, which is part of the RAMP tool, is based on research-based studies combined with expert group judgments. More than 80 practitioners participated in the development of RAMP I. The tool consists of dichotomous assessment items grouped into seven categories. Acceptable reliability was found for a majority of the assessment items for 15 practitioners who were given 1?h of training. The usability evaluation points to RAMP I being usable for screening for musculoskeletal disorder risk factors, i.e., usable for assessing risks, being usable as a decision base, having clear results and that the time needed for an assessment is acceptable. It is concluded that RAMP I is a usable tool for practitioners.     

A proactive process risk assessment approach based on job hazard analysis and resilient engineering

Complex systems often experience a long period of incubation before accidents occur. Therefore, a proactive risk assessment is essential for process safety. The conventional job hazard analysis (JHA) method has been an effective tool to conduct a process risk assessment in the high-risk industrial field. However, the conventional JHA is inadequate for the proactive risk assessment since it is usually conducted during and before one specific operation process. Operations such as startup and maintenance are performed repeatedly on the lifecycle of a plant. Therefore, the risk reduction measures for the industrial process should include not only preventive actions obtained from the conventional JHA but also recovery ones. Resilience engineering (RE) has proven to be helpful for the recovery analysis of a complex system. The objective of this paper is to propose a proactive and comprehensive process risk assessment approach based on JHA and RE. The mechanism of applying RE to address operation process risk is illustrated. The integrated approach can provide guidelines to establish proactive risk reduction measures as well as maintain a low-risk level. Finally, a gas transmission startup process risk assessment case is presented to demonstrate its applicability.     

ARSENIC CONSUMPTION AND HEALTH RISK PERCEPTIONS IN A RURAL WESTERN U.S. AREA1

ABSTRACT: Churchill County, Nevada, has approximately 23,000 residents, among whom an estimated 13,500 relied on private wells for water supply in 2002. This study examined exposure to arsenic in water supplies among residents with private domestic wells and factors related to householder choice to consume tap water. It compared opinions and concerns about water quality with consumption habits and observed concentrations from tap water samples. The results from 351 households indicated that a majority (75 percent) of respondents consumed tap water and that a minority (38 percent) applied treatment. Approximately 66 percent of those who consumed tap water were exposed to concentrations of arsenic that exceeded 10 ppb. Water consumption was related to application of treatment. Among 98 respondents who were not at all concerned about the health effects of aqueous arsenic, 59 (60 percent) reported consuming tap water with concentrations of arsenic exceeding 10 ppb. Conversely, among 86 respondents who were highly concerned about arsenic, 33 (37 percent) consumed tap water with concentrations of arsenic exceeding 10 ppb. Results from a national sampling effort showed that 620 of 5,304 private wells sampled (11.7 percent) had arsenic concentrations above 10 ppb. The paradox of awareness of arsenic in water supplies coupled with consumption of aqueous arsenic in concentrations greater than 10 ppb may be common in other parts of the nation. Enhanced educational efforts, especially related to tap water sampling and explanations of efficacy of available treatment, may be useful means of reducing exposure through private water supplies.     

Epidemiologic Analysis of Factors Associated with Local Disappearances of Native Ranid Frogs in Arizona

Abstract:  We examined factors that may independently or synergistically contribute to amphibian population declines. We used epidemiologic case–control methodology to sample and analyze a large database developed and maintained by the Arizona Game and Fish Department that describes historical and currently known ranid frog localities in Arizona, U.S.A. Sites with historical documentation of target ranid species ( n = 324) were evaluated to identify locations where frogs had disappeared during the study period (case sites) and locations where frog populations persisted (control sites). Between 1986 and 2003, 117 (36%) of the 324 sites became case sites, of which 105 were used in the analyses. An equal number of control sites were sampled to control for the effects of time. Risk factors, or predictor variables, were defined from environmental data summarized during site surveys and geographic information system data layers. We evaluated risk factors with univariate and multifactorial logistic-regression analyses to derive odds ratios (OR). Odds for local population disappearance were significantly related to 4 factors in the multifactorial model. Disappearance of frog populations increased with increasing elevation (OR = 2.7 for every 500 m, p < 0.01). Sites where disappearances occurred were 4.3 times more likely to have other nearby sites that also experienced disappearances (OR = 4.3, p < 0.01), whereas the odds of disappearance were 6.7 times less (OR = 0.15, p < 0.01) when there was a source population nearby. Sites with disappearances were 2.6 times more likely to have introduced crayfish than were control sites (OR = 2.6, p = 0.04). The identification of factors associated with frog disappearances increases understanding of declines occurring in natural populations and aids in conservation efforts to reestablish and protect native ranids by identifying and prioritizing implicated threats.     

Risk-evaluation of Hi-tech Enterprise in the Process of Approaching Global Market

In the high technology industry, small and medium sized technology enterprises (SMSTEs) play a pivotal role in advancing the whole industry. To achieve sustainable development, they need to extend their scope of business activities beyond a national view and exploit international market actively to meet international competitions that increase quickly in the form of allocating resources within the scope of the world. However, the SMSTEs are also facing risks associated with themselves during the process of exploiting international market owing to their own restrictions, so what they should do is to consider risk evaluations in exploiting the international market.     

Prenatal diagnosis of Apert syndrome: report of two cases

Two de novo cases with Apert Syndrome detected prenatally are presented herein. In the first, fetal ultrasound findings of syndactyly of the hands, craniosynostosis and proptosis resulted in a prenatal diagnosis in the nineteenth week of gestation. This is the earliest prenatal diagnosis of this syndrome in a not-at-risk case. Following counseling, this pregnancy was terminated and subsequent pathological examination and DNA analysis confirmed the diagnosis of Apert Syndrome and coarctation of the aorta. In the second case, fetal ultrasound at 21 weeks' gestation revealed a hypoplastic left heart and clover-leaf skull. Following counseling, this pregnancy was also terminated. Further examination of the fetus and DNA analysis led to a diagnosis of Apert Syndrome. These cases emphasize the need to complete a thorough fetal ultrasound in cases with potentially lethal cardiac abnormality and the importance of incorporating a fetal pathologist, as well as a medical geneticist, in the investigations performed after delivery or pregnancy termination when a fetal abnormality is detected on ultrasound. Copyright © 2003 John Wiley & Sons, Ltd.     

企业开展HSE危害识别及风险评估的现状与对策

结合本单位建立与实施HSE管理体系实际，分析了企业开展危害识别与风险评估中常见的问题，提出了解决问题的初步方法。     

生态足迹影响因子的定量分析

人口的膨胀和人类工业化进程的加剧，使得人类向自然界获取越来越多的资源，同时向环境源源不断的输入废弃物，已经严重超过了自然生态系统的供给能力和环境容量，生态环境日益恶化，水土流失、草场退化、植被消亡、生物多样性锐减、全球变暖等情况已经严重到难以遏制的地步，危及到人类自身的生存。在和平与发展成为世界两大主题的今天，人们越来越关注可持续发展的问题。在现有资料的基础上，利用主成分分析方法，定量地讨论了中国各省（区市）1999年生态足迹大小与其影响因子间的关系。结果表明，生态足迹的大小是各省（区市）的大中型企业个数、全社会固定生产投资等众多因子共同作用的结果，其中总人口和GDP是生态足迹大小的主要影响因子，其因子载荷量分别达到了0.940和0.913。值得一提的是非农业人口与生态足迹的相关系数超过了农业人口，这说明由于消费模式和生活水平等的差异，非农业人口对生态足迹的影响大于农业人口对生态足迹的影响。在此基础上建立了生态足迹影响因子的多元线性回归模型，以期为生态足迹在进行区域可持续发展评价的方法上提供新的思路。     

中国可持续社会养老保险的综合评价体系和实证分析

我国可持续社会养老保险的综合评价指标体系包括四个层次和三级子系统，内容涉及养老保险人数、机构设置、基金管理和代际平衡四个子目标。应用因子分析模糊综合评价方法对我国1990-2001年养老保险建设状况进行评价，本文认为基金管理，行政管理和代际失衡是影响我国可持续养老保险发展的主要因素。     

Pitfalls in molecular diagnosis in a family with severe factor VII (FVII) deficiency—misdiagnosis by direct sequence analysis using a PCR product

Molecular diagnostic tests are becoming a routine analysis in many laboratories. These modern analyses are widely used in clinical medicine, forensic, genetic and prenatal diagnosis and also in preimplantation genetic diagnosis. The accuracy of analysis is highly dependent on the success achieved in minimising genotyping errors. The pitfalls in molecular diagnostic tests can be due to a simple technique such as the polymerase chain reaction (PCR) used universally. This technique is routinely used for its apparent accuracy, but it is also a well-known source of errors. We report an error introduced during PCR reaction that leads to a wrong sequence result and consequently to a ‘false’ molecular result in a next prenatal diagnosis in a family with severe factor VII (FVII) deficiency. This error was verified using an unsuitable primer design in a rich repetitive sequence of the FVII gene that leads to a false annealing and then to a wrong molecular diagnosis. It is essential to link closely molecular data with clinical and phenotype analysis in order to avoid false-negative or false-positive results, which is of great importance to diagnosis and molecular prevention. Copyright © 2003 John Wiley & Sons, Ltd.